Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer

World Journal of Gastroenterology

Volumn 11, Issue 25, 2005, Pages 3830-3833

  Wang, Guang Yi ^a   Ji, Bai ^a   Wang, Xu ^a   Gu, Jian Hua ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Angiogenesis inhibitors; Inducible nitric oxide synthase; Microvessel density; Stomach neoplasms; Vascular endothelial growth factor

Indexed keywords

AMINOGUANIDINE; CYCLINE; EOSIN; HEMATOXYLIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOMYCIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DISEASE MODEL; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SELECTIVITY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; METASTASIS POTENTIAL; MICROVASCULATURE; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 22644432694     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i25.3830     Document Type: Article

References (21)

1. Sun XD, Mu R, Zhou YS, Dai XD, Zhang SW, Huangfu XM, Sun J, Li LD, Lu FZ, Qiao YL. Analysis of mortality rate of stomach cancer and its trend in twenty years in China. Zhonghua Zhongliu Zazhi 2004; 26: 4-9
2. Feng CW, Wang LD, Jiao LH, Liu B, Zhang S, Xie XJ. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2002; 2: 8
3. Koh E, Noh SH, Lee YD, Lee HY, Han JW, Lee HW, Hong S. Differential expression of nitric oxide synthase in human stomach cancer. Cancer Lett 1999; 146: 173-180
4. Doi C, Noguchi Y, Marat D, Saito A, Fukuzawa K, Yoshikawa T, Tsuburaya A, Ito T. Expression of nitric oxide synthase in gastric cancer. Cancer Lett 1999; 144: 161-167
5. Eroglu A, Demirci S, Ayyildiz A, Kocaoglu H, Akbulut H, Akgul H, Elhan HA. Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer. Br J Cancer 1999; 80: 1630-1634
6. Lee JC, Chow NH, Wang ST, Huang SM. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 2000; 36: 748-753
7. Mattern J, Koomagi R, Volm M. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res 1997; 17: 2249-2252
8. Wang GY, Gu JH, Lu GY, Meng XY. Effets of aminoguanidine on transplantation stomach cancer in mice. J Jilin University 2004; 30: 409-412
9. Wang GY, Wang X. Relationship between tumor angiogenesis and expression of vascular endothelial growth factor and nitric oxide synthase in human gastric cancer. Zhongguo Puwai Jichu Yu Linchuang Zazhi 2004; 11: 55-57
10. Wang X, Wang GY. Expression of vascular endothelial growth factor and nitric oxide synthase in human gastric cancer and its relation to angiogenesis and clinical pathology. Zhonghua Weichang Waike Zazhi 2002; 5: 145-148
11. Farsky SH, Borelli P, Fock RA, Proto SZ, Ferreira JM Jr, Mello SB. Chronic blockade of nitric oxide biosynthesis in rats: effect on leukocyte endothelial interaction and on leukocyte recruitment. Inflamm Res 2004; 53: 442-452
12. Tong BC, Barbul A. Cellular and physiological effects of arginine. Mini Rev Med Chem 2004; 4: 823-832
13. Lala PK, Orucevic A. Role of nitric oxide in tumor progression: lessons from human tumors. Cancer Metastasis Rev 1998; 17: 91-106
14. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncadas S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92: 4392-4396
15. Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G, Tahara E. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinoma. Clin Cancer Res 1998; 4: 2195-2200
16. Salvucci O, Carsana M, Bersani I, Tragni G, Anichini A. Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res 2001; 61: 318-326
17. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-storchi I, Vergari WA, Ziche M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998; 90: 587-596
18. Rieder G, Hofmann JA, Hatz RA, Stolte M, Enders GA. Upregulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type. Int J Med Microbiol 2003; 293: 403-412
19. Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis,administered along or in combination with Celecoxib, a selective Cyclooxygenase-2 inhibitor. Cancer Res 2002; 62: 165-170
20. Jung ID, Yang SY, Park CG, Lee KB, Kim JS, Lee SY, Han JW, Lee HW, Lee HY. 5-Fluorouracil inhibits nitric oxide production through the inactivation of IkappaB kinase in stomach cancer cells. Biochem Pharmacol 2002; 64: 1439-1445
21. Chen T, Nines RG, Peschke SM, Kresty LA, Stoner GD. Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis. Cancer Res 2004; 64: 3714-3717